Zobrazeno 1 - 10
of 71
pro vyhledávání: '"J. Potenberg"'
Autor:
O. Gluz, S. Kuemmel, U. Nitz, M. Braun, K. Lüdtke-Heckenkamp, R. von Schumann, M. Darsow, H. Forstbauer, J. Potenberg, C. Uleer, E.M. Grischke, B. Aktas, C. Schumacher, C. zu Eulenburg, R. Kates, K. Jóźwiak, M. Graeser, R. Wuerstlein, R. Baehner, M. Christgen, H.H. Kreipe, N. Harbeck
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd3d8191252985fd5dca3bf69c2d0aa3
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85161261189
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85161261189
Autor:
J Holtschmidt, H. Harrach, J. Lubitz, S. Kuemmel, J Potenberg, E. Traut, A Kostara, V. Hanf, J-U Blohmer, Peter Dall, P. Deuschle, Mattea Reinisch, S.-T. Graßhoff, E Breit, C. Seiberling, K Hellerhoff, A Rueland, Julia Dorn, C. Ankel, D Schindowski, G Kaltenecker, Jörg Heil, K Belke
Publikováno v:
Senologie - Zeitschrift für Mammadiagnostik und -therapie.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93f84a719c1fcf9fa92e55cc3fa2d4a5
https://doi.org/10.1055/s-0041-1730207
https://doi.org/10.1055/s-0041-1730207
Autor:
U.A. Nitz, O. Gluz, M. Christgen, E.-M. Grischke, D. Augustin, S. Kuemmel, M. Braun, J. Potenberg, A. Kohls, K. Krauss, A. Stefek, C. Schumacher, H. Forstbauer, T. Reimer, H. Fischer, C. Liedtke, R. Wuerstlein, J. Schumacher, R. Kates, H. Kreipe, N. Harbeck
Publikováno v:
Annals of Oncology. 33:355
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2aa82c71abd9ce873922e5cbcb93b46a
https://doi.org/10.1016/j.annonc.2021.12.008
https://doi.org/10.1016/j.annonc.2021.12.008
Autor:
J. Potenberg, R Kates, C Matthias, H.H. Kreipe, Stefan Kraemer, Anke Kleine-Tebbe, Bahriye Aktas, Doris Augustin, Rachel Wuerstlein, S Kümmel, Claudia Schumacher, O Gluz, Michael Braun, Nadia Harbeck, J. Tio, Helmut Forstbauer, U. Nitz, SL de Haas, Cornelia Liedtke, Regula Deurloo, E-M Grischke, Johannes Schumacher
Publikováno v:
Cancer Research. 77:P1-09
Background: Immune and apoptosis biomarkers are potential prognostic/predictive markers in HER2+ EBC. High PD-L1 expression was shown to be predictive for lower pCR after chemotherapy+trastuzumab+/-pertuzumab, particularly in HER2+, ER- disease. Yet,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4eca94b3dcb35a95e34837233e558471
https://doi.org/10.1158/1538-7445.sabcs16-p1-09-05
https://doi.org/10.1158/1538-7445.sabcs16-p1-09-05
Autor:
J. Potenberg, Rachel Wuerstlein, Doris Augustin, O Gluz, C. Kolberg-Liedtke, J. Palatty, Christine Eulenburg, U. Nitz, S. Kuemmel, E-M. Grischke, D. Ulbrich-Gebauer, Friedrich Feuerhake, C. Biehl, Matthias Christgen, Michael Braun, Nadia Harbeck, Monika Graeser, H.H. Kreipe, R Kates
Publikováno v:
Annals of Oncology. 32:S48
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80804feb41e04c47a8210d278113c12d
https://doi.org/10.1016/j.annonc.2021.03.215
https://doi.org/10.1016/j.annonc.2021.03.215
Autor:
O Gluz, U Nitz, C Liedtke, M Christgen, K Sotlar, EM Grischke, H Forstbauer, M Braun, M Warm, J Hackmann, C Uleer, B Aktas, C Schumacher, N Bangemann, C Lindner, S Kuemmel, M Clemens, J Potenberg, P Staib, A Kohls, E Pelz, RE Kates, R Wuerstlein, HH Kreipe, N Harbeck
Publikováno v:
Cancer Research. 76:P1-13
Background: Pathological complete response (pCR) is associated with improved prognosis in TNBC, but optimal chemotherapy remains unclear. Use of weekly nab- paclitaxel (Nab-Pac) vs. conventional paclitaxel and also addition of carboplatinum(Carbo) to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28ec0028dade12c7f6d8707a83b26b3e
https://doi.org/10.1158/1538-7445.sabcs15-p1-13-01
https://doi.org/10.1158/1538-7445.sabcs15-p1-13-01
Autor:
D. Semsek, B. Timm, C.D. Fichter, A. Köhler, Thomas Göhler, L. Jacobasch, V. Kächele, J. Potenberg, M. Reiser, K. Potthoff, H.U. Siebenbach, Norbert Marschner, Jens Uhlig, P. Stübs, Lothar Müller
Publikováno v:
Annals of Oncology. 31:S436
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec0f722a68b462d020407b714fe0d993
https://doi.org/10.1016/j.annonc.2020.08.568
https://doi.org/10.1016/j.annonc.2020.08.568
Autor:
Joachim Alfer, Holger Eidtmann, Nicole Burchardi, Toralf Reimer, Jens Huober, Valentina Nekljudova, John Hackmann, B. Conrad, Gunter von Minckwitz, Christoph Thomssen, Elmar Stickeler, Carsten Denkert, Wolfgang Eiermann, Thomas Decker, Christian Jackisch, Volker Möbus, J. Potenberg, Eike Simon, Frederik Marmé, Sibylle Loibl
Publikováno v:
Cancer. 121:3639-3648
BACKGROUND Although greater than 40% of breast cancers occur in patients aged ≥65 years, these individuals are frequently undertreated. Taxane-based adjuvant chemotherapy is considered the treatment of choice but to the authors' knowledge has only
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c948e4453d4bbed967fc2f080c6177f6
https://doi.org/10.1002/cncr.29506
https://doi.org/10.1002/cncr.29506
Autor:
Rachel Wuerstlein, Oleg Gluz, Daniel Hofmann, Michael Braun, Helmut Forstbauer, Bahriye Aktas, Ronald E. Kates, J. Potenberg, Claudia Schumacher, Nadia Harbeck, Kuemmel Sherko, Hans Kreipe, Matthias Christgen, Ulrike Nitz, Toralf Reimer, Peter A. Fasching, Kraemer Stefan
Publikováno v:
Cancer Research. 75:P4-15
Background: HER2+, hormone receptor-positive (HR+) breast cancer is a distinct subtype associated with good prognosis but poor response to standard chemotherapy + anti-HER2 (single or dual blockade). Substantial overtreatment by poly-chemotherapy com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4dddd17e4cdf8c2e3fcee52b637cbf7
https://doi.org/10.1158/1538-7445.sabcs14-p4-15-01
https://doi.org/10.1158/1538-7445.sabcs14-p4-15-01
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.